Invivyd (IVVD) Return on Capital Employed (2021 - 2025)
Invivyd posted quarterly Return on Capital Employed of 31.96% for Q4 2025, up 17926.0% year-on-year from N/an in Q4 2024, and up 64.23% on a QoQ basis from 89.35% in Q3 2025.
Invivyd (IVVD) has 5 years of Return on Capital Employed data on file, last reported at 31.96% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed rose 17926.0% year-over-year to 31.96%; the trailing twelve-month figure through Dec 2025 stood at 31.96% (up 17926.0% YoY), and the FY2025 full-year result was 32.87%, up 11783.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 31.96%, up from 89.35% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 31.96% in Q4 2025 and bottomed at 257.32% in Q3 2024.
- The 5-year median for Return on Capital Employed is 69.25% (2022), against an average of 109.97%.
- The widest annual swing landed in 2024, when Return on Capital Employed slumped 18868 bps; it then soared 17926 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 38.39% in 2021, then sank by 71 bps to 65.46% in 2022, then slumped by 61 bps to 105.45% in 2023, then tumbled by 100 bps to 211.21% in 2024, then soared by 85 bps to 31.96% in 2025.
- The last three Return on Capital Employed figures came in at 31.96% (Q4 2025), 89.35% (Q3 2025), and 218.35% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 21.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.19% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.34% |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | -31.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.96% |
| Sep 30, 2025 | -89.35% |
| Jun 30, 2025 | -218.35% |
| Mar 31, 2025 | -220.35% |
| Dec 31, 2024 | -211.21% |
| Sep 30, 2024 | -257.32% |
| Jun 30, 2024 | -134.72% |
| Mar 31, 2024 | -118.17% |
| Dec 31, 2023 | -105.45% |
| Sep 30, 2023 | -68.64% |
| Jun 30, 2023 | -62.73% |
| Mar 31, 2023 | -54.05% |
| Dec 31, 2022 | -65.46% |
| Sep 30, 2022 | -69.25% |
| Jun 30, 2022 | -65.40% |
| Mar 31, 2022 | -58.65% |
| Dec 31, 2021 | -38.39% |